GLP-1 Telehealth Red Flags: 10 Warning Signs Your Provider Isn't Legit
Not every GLP-1 telehealth platform operates with your health as the top priority. Some are optimized for speed and volume — getting you a prescription as fast as possible with as little clinical oversight as necessary. Here are ten warning signs that a telehealth GLP-1 provider may not be legitimate or safe.
1. No Video or Phone Consultation
If the entire "consultation" is a web form you fill out in three minutes, there's no clinical assessment happening. Legitimate GLP-1 prescribing involves a conversation — ideally by video — where a licensed provider reviews your medical history, asks follow-up questions, and explains the medication's risks and benefits. A questionnaire alone cannot substitute for clinical judgment.
2. No Lab Work Required — Ever
GLP-1 medications affect metabolic, renal, and thyroid function. Baseline labs — at minimum a metabolic panel and thyroid markers — help identify contraindications and establish benchmarks for monitoring. Platforms that never ask about labs and never order them are skipping a standard safety step.
Some platforms accept recent labs from your primary care provider, which is reasonable. But "no labs needed, ever" is a red flag.
3. They Won't Tell You Who Your Prescriber Is
If a platform won't share the name, credentials, or state licensure of the prescriber who will manage your care, something is wrong. You have the right to know who is prescribing your medication. Reluctance to share this information often means the platform is routing patients through a high-volume medical group where individual prescriber accountability is low.
4. Guaranteed Prescriptions
"Get your prescription today — guaranteed!" is a marketing promise that no ethical medical provider can make. A prescription is a clinical decision based on individual patient assessment. If a platform guarantees approval before evaluating you, the evaluation is performative.
5. No Mention of Contraindications
GLP-1 medications have clear contraindications: personal or family history of medullary thyroid carcinoma (MTC), MEN-2 syndrome, history of pancreatitis, severe gastrointestinal disease, and pregnancy. If the platform's website, intake process, and prescriber consultation never mention any of these, the clinical screening is inadequate.
6. No Follow-Up Schedule
GLP-1 dose titration requires clinical monitoring. Side effects like nausea, constipation, and injection site reactions are common during the first weeks. Dose increases should happen at clinically appropriate intervals, not on a fixed schedule regardless of patient response. If the platform's model is "here's your medication, call us if something goes wrong," the ongoing care component is missing.
7. Unverifiable Pharmacy Claims
If the platform says their compounding pharmacy is "FDA-approved" (compounding pharmacies are registered, not approved), or won't name the pharmacy at all, proceed with caution. A legitimate platform will name its pharmacy partners and provide verifiable credentials — 503A or 503B registration, state licensing, and ideally PCAB accreditation.
8. Prices That Seem Impossibly Low
Compounded semaglutide has real costs — active pharmaceutical ingredient, sterile compounding labor, cold-chain shipping, clinical oversight. If a platform offers GLP-1 prescriptions for $50/month with no membership fee, either the clinical oversight is minimal, the medication quality is questionable, or the business model relies on upselling you later. Legitimate compounded semaglutide typically starts in the $130–$200/month range depending on dose.
9. Aggressive Social Media Testimonials
Before-and-after photos with dramatic weight loss claims ("I lost 40 pounds in 6 weeks!") are marketing, not clinical evidence. GLP-1 clinical trials show average weight loss of 15–20% of body weight over 68 weeks — not six weeks. Platforms that lead with extreme outlier results are prioritizing conversion over informed consent.
10. No Physical Business Address
A telehealth company should have a verifiable business entity registered with a state Secretary of State's office, a physical mailing address (not just a P.O. box), and clear ownership information. Companies that hide behind anonymity make it difficult for patients to pursue complaints or refunds if something goes wrong.
What Good Looks Like
The flip side of every red flag is a green flag. Here are providers that demonstrate transparent, safe practices.
Embody — $149/mo
Injectable semaglutide · Custom intake · Clinician-matched
Get Started →Paid link · Compounded medications are not FDA-approved and are made by state-licensed pharmacies.
Gala — $179/mo flat
Compounded sema & tirz · Locked pricing at any dose
Get Started →Paid link · Compounded medications are not FDA-approved and are made by state-licensed pharmacies.
Yucca Health — $146/mo
Lowest intro price · Tirz from $258/mo
Get Started →Paid link · Compounded medications are not FDA-approved and are made by state-licensed pharmacies.
If you've encountered a problematic provider: Report it to the FDA's MedWatch program, your state medical board, and your state Attorney General's consumer protection division. Your report helps protect other patients.